The main purpose of the study is to determine the Maximum Tolerated Dose (MTD), the Recommended Expansion Dose and the safety and tolerability of ADCE-B05 when…

Solid Tumors (Phase 1)

~Estimated

~$10 – $7,500

Adcendo ApSNCT07362888

Phase 1

A Multi-center, Open-label, Phase I Study Evaluating the Safety, Tolerability, Pharmacokinetics and Anti-tumor Activity of AN9025 in Participants With Advanced or Metastatic Solid Tumors Harboring RAS Mutations

The goal of this clinical trial is to learn determine if AN9025 is safe and tolerable to treat solid cancer tumors with specific genetic mutations. It will hel…

Solid Tumors (Phase 1)RAS Mutation

~Estimated

~$10 – $8,750

Adlai Nortye Biopharma Co., Ltd.NCT07252479